RET rearrangements and BRAF mutation in undifferentiated thyroid carcinomas having papillary carcinoma components

Kunio Mochizuki, Tetsuo Kondo, Tadao Nakazawa, Masanori Iwashina, Tomonori Kawasaki, Nobuki Nakamura, Tetsu Yamane, Shin Ichi Murata, Koichi Ito, Kaori Kameyama, Makio Kobayashi, Ryohei Katoh

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Aims: To elucidate the genetic background of anaplastic transformation, RET rearrangements and BRAF mutation were studied in composite undifferentiated carcinomas (UCs) of the thyroid, which are UCs having papillary carcinoma (PC) components. Methods and results: Reverse transcription-polymerase chain reaction (RT-PCR) was performed for RET rearrangements and PCR for BRAF mutation in UC and PC components that were microdissected separately from seven composite UCs. Forty-two thyroid cancers with single component histology (14 UCs and 28 PCs) were also studied in the same manner. RET/PTC1 was undetectable in both components from all seven composite UCs, and RET/PTC3 was identified in both components of one composite UC. BRAF mutation was identified in both components from three composite UCs and only in the PC components from two composite UCs. In contrast, in thyroid carcinomas with single component histology, RET/PTC1 was detected in 11% of PCs and in none of the UCs, and RET/PTC3 was not found in any of the tumours studied. BRAF mutation was identified in 82% of PCs and in 21% of UCs. Conclusions: The high frequency of BRAF mutation and the absence of RET rearrangements in UC components from composite UCs supports the hypothesis that UCs may actually represent progressive malignant degeneration of a BRAF-mutated, well-differentiated thyroid carcinoma.

Original languageEnglish
Pages (from-to)444-450
Number of pages7
JournalHistopathology
Volume57
Issue number3
DOIs
Publication statusPublished - 2010 Sep

Fingerprint

Papillary Carcinoma
Thyroid Neoplasms
Carcinoma
Mutation
Histology
Polymerase Chain Reaction
Mutation Rate
Reverse Transcription
Thyroid Gland

Keywords

  • anaplastic transformation
  • BRAF mutation
  • papillary thyroid carcinoma
  • RET rearrangements
  • undifferentiated thyroid carcinoma

ASJC Scopus subject areas

  • Histology
  • Pathology and Forensic Medicine

Cite this

Mochizuki, K., Kondo, T., Nakazawa, T., Iwashina, M., Kawasaki, T., Nakamura, N., ... Katoh, R. (2010). RET rearrangements and BRAF mutation in undifferentiated thyroid carcinomas having papillary carcinoma components. Histopathology, 57(3), 444-450. https://doi.org/10.1111/j.1365-2559.2010.03646.x

RET rearrangements and BRAF mutation in undifferentiated thyroid carcinomas having papillary carcinoma components. / Mochizuki, Kunio; Kondo, Tetsuo; Nakazawa, Tadao; Iwashina, Masanori; Kawasaki, Tomonori; Nakamura, Nobuki; Yamane, Tetsu; Murata, Shin Ichi; Ito, Koichi; Kameyama, Kaori; Kobayashi, Makio; Katoh, Ryohei.

In: Histopathology, Vol. 57, No. 3, 09.2010, p. 444-450.

Research output: Contribution to journalArticle

Mochizuki, K, Kondo, T, Nakazawa, T, Iwashina, M, Kawasaki, T, Nakamura, N, Yamane, T, Murata, SI, Ito, K, Kameyama, K, Kobayashi, M & Katoh, R 2010, 'RET rearrangements and BRAF mutation in undifferentiated thyroid carcinomas having papillary carcinoma components', Histopathology, vol. 57, no. 3, pp. 444-450. https://doi.org/10.1111/j.1365-2559.2010.03646.x
Mochizuki, Kunio ; Kondo, Tetsuo ; Nakazawa, Tadao ; Iwashina, Masanori ; Kawasaki, Tomonori ; Nakamura, Nobuki ; Yamane, Tetsu ; Murata, Shin Ichi ; Ito, Koichi ; Kameyama, Kaori ; Kobayashi, Makio ; Katoh, Ryohei. / RET rearrangements and BRAF mutation in undifferentiated thyroid carcinomas having papillary carcinoma components. In: Histopathology. 2010 ; Vol. 57, No. 3. pp. 444-450.
@article{fa7bfe0bdc04455aafaa9864fdee9362,
title = "RET rearrangements and BRAF mutation in undifferentiated thyroid carcinomas having papillary carcinoma components",
abstract = "Aims: To elucidate the genetic background of anaplastic transformation, RET rearrangements and BRAF mutation were studied in composite undifferentiated carcinomas (UCs) of the thyroid, which are UCs having papillary carcinoma (PC) components. Methods and results: Reverse transcription-polymerase chain reaction (RT-PCR) was performed for RET rearrangements and PCR for BRAF mutation in UC and PC components that were microdissected separately from seven composite UCs. Forty-two thyroid cancers with single component histology (14 UCs and 28 PCs) were also studied in the same manner. RET/PTC1 was undetectable in both components from all seven composite UCs, and RET/PTC3 was identified in both components of one composite UC. BRAF mutation was identified in both components from three composite UCs and only in the PC components from two composite UCs. In contrast, in thyroid carcinomas with single component histology, RET/PTC1 was detected in 11{\%} of PCs and in none of the UCs, and RET/PTC3 was not found in any of the tumours studied. BRAF mutation was identified in 82{\%} of PCs and in 21{\%} of UCs. Conclusions: The high frequency of BRAF mutation and the absence of RET rearrangements in UC components from composite UCs supports the hypothesis that UCs may actually represent progressive malignant degeneration of a BRAF-mutated, well-differentiated thyroid carcinoma.",
keywords = "anaplastic transformation, BRAF mutation, papillary thyroid carcinoma, RET rearrangements, undifferentiated thyroid carcinoma",
author = "Kunio Mochizuki and Tetsuo Kondo and Tadao Nakazawa and Masanori Iwashina and Tomonori Kawasaki and Nobuki Nakamura and Tetsu Yamane and Murata, {Shin Ichi} and Koichi Ito and Kaori Kameyama and Makio Kobayashi and Ryohei Katoh",
year = "2010",
month = "9",
doi = "10.1111/j.1365-2559.2010.03646.x",
language = "English",
volume = "57",
pages = "444--450",
journal = "Histopathology",
issn = "0309-0167",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - RET rearrangements and BRAF mutation in undifferentiated thyroid carcinomas having papillary carcinoma components

AU - Mochizuki, Kunio

AU - Kondo, Tetsuo

AU - Nakazawa, Tadao

AU - Iwashina, Masanori

AU - Kawasaki, Tomonori

AU - Nakamura, Nobuki

AU - Yamane, Tetsu

AU - Murata, Shin Ichi

AU - Ito, Koichi

AU - Kameyama, Kaori

AU - Kobayashi, Makio

AU - Katoh, Ryohei

PY - 2010/9

Y1 - 2010/9

N2 - Aims: To elucidate the genetic background of anaplastic transformation, RET rearrangements and BRAF mutation were studied in composite undifferentiated carcinomas (UCs) of the thyroid, which are UCs having papillary carcinoma (PC) components. Methods and results: Reverse transcription-polymerase chain reaction (RT-PCR) was performed for RET rearrangements and PCR for BRAF mutation in UC and PC components that were microdissected separately from seven composite UCs. Forty-two thyroid cancers with single component histology (14 UCs and 28 PCs) were also studied in the same manner. RET/PTC1 was undetectable in both components from all seven composite UCs, and RET/PTC3 was identified in both components of one composite UC. BRAF mutation was identified in both components from three composite UCs and only in the PC components from two composite UCs. In contrast, in thyroid carcinomas with single component histology, RET/PTC1 was detected in 11% of PCs and in none of the UCs, and RET/PTC3 was not found in any of the tumours studied. BRAF mutation was identified in 82% of PCs and in 21% of UCs. Conclusions: The high frequency of BRAF mutation and the absence of RET rearrangements in UC components from composite UCs supports the hypothesis that UCs may actually represent progressive malignant degeneration of a BRAF-mutated, well-differentiated thyroid carcinoma.

AB - Aims: To elucidate the genetic background of anaplastic transformation, RET rearrangements and BRAF mutation were studied in composite undifferentiated carcinomas (UCs) of the thyroid, which are UCs having papillary carcinoma (PC) components. Methods and results: Reverse transcription-polymerase chain reaction (RT-PCR) was performed for RET rearrangements and PCR for BRAF mutation in UC and PC components that were microdissected separately from seven composite UCs. Forty-two thyroid cancers with single component histology (14 UCs and 28 PCs) were also studied in the same manner. RET/PTC1 was undetectable in both components from all seven composite UCs, and RET/PTC3 was identified in both components of one composite UC. BRAF mutation was identified in both components from three composite UCs and only in the PC components from two composite UCs. In contrast, in thyroid carcinomas with single component histology, RET/PTC1 was detected in 11% of PCs and in none of the UCs, and RET/PTC3 was not found in any of the tumours studied. BRAF mutation was identified in 82% of PCs and in 21% of UCs. Conclusions: The high frequency of BRAF mutation and the absence of RET rearrangements in UC components from composite UCs supports the hypothesis that UCs may actually represent progressive malignant degeneration of a BRAF-mutated, well-differentiated thyroid carcinoma.

KW - anaplastic transformation

KW - BRAF mutation

KW - papillary thyroid carcinoma

KW - RET rearrangements

KW - undifferentiated thyroid carcinoma

UR - http://www.scopus.com/inward/record.url?scp=77956629969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956629969&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2559.2010.03646.x

DO - 10.1111/j.1365-2559.2010.03646.x

M3 - Article

C2 - 20840674

AN - SCOPUS:77956629969

VL - 57

SP - 444

EP - 450

JO - Histopathology

JF - Histopathology

SN - 0309-0167

IS - 3

ER -